An, JaeJin <br/><br/>
Stroke and Bleeding Risk Associated With Antithrombotic Therapy for Patients With Nonvalvular Atrial Fibrillation in Clinical Practice.  [electronic resource] 

 -  Journal of the American Heart Association  Jul 2015 
<br/><br/> Publication Type: Comparative Study; Journal Article; Observational Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2047-9980 
<br/><br/><label>Standard No.: </label>10.1161/JAHA.115.001921  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Aspirin--adverse effects<br/>Atrial Fibrillation--blood<br/>Blood Coagulation--drug effects<br/>California--epidemiology<br/>Comorbidity<br/>Drug Monitoring--methods<br/>Female<br/>Fibrinolytic Agents--adverse effects<br/>Health Maintenance Organizations<br/>Hemorrhage--chemically induced<br/>Humans<br/>International Normalized Ratio<br/>Longitudinal Studies<br/>Male<br/>Middle Aged<br/>Retrospective Studies<br/>Risk Assessment<br/>Risk Factors<br/>Stroke--blood<br/>Time Factors<br/>Treatment Outcome<br/>Warfarin--adverse effects